| Systematic (IUPAC) name | |
|---|---|
| (1R,5S)-(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)-4-fluorobenzoate | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | insufflated |
| Identifiers | |
| CAS number | 172883-97-5 |
| ATC code | ? |
| PubChem | CID 5147770 |
| ChemSpider | 4321292 |
| Chemical data | |
| Formula | C15H18FNO2 |
| Mol. mass | 263.307 |
| SMILES | eMolecules & PubChem |
|
|
| |
|
3β-(p-Fluorobenzoyloxy)tropane, (8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 4-fluorobenzoic acid ester, 4-fluorotropacocaine, 3-pseudotropyl-4-fluorobenzoate, pFBT) is a tropane derivative drug which acts as a local anaesthetic, having around 30% the stimulant potency of cocaine but around the same potency as a local anaesthetic.[citation needed] It has been investigated as a potential radiolabelled agent for studying receptor binding,[1] but was not adopted for this application. The main application for fluorotropacocaine however has been as a designer drug analogue of cocaine, first detected by the EMCDDA in 2008,[2][3] and subsequently sold as an ingredient of various "bath salt" powder products, usually mixed in combination with other stimulant drugs such as caffeine, dimethocaine, desoxypipradrol or substituted cathinone derivatives.[4][5]
|
|||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)